You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 139 No. 9, September 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Evidence-Based Dermatology: Review
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Evidence-Based Medicine
 •Randomized Controlled Trial
 •Dermatology, Other
 •Alert me on articles by topic

Applying Trial Evidence Back to the Patient

Hywel C. Williams, MSc, PhD, FRCP

Arch Dermatol. 2003;139:1195-1200.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

Applying external trial evidence to the patient sitting in front of you in the clinical setting is perhaps one of the most difficult and least discussed steps of evidence-based medicine.1-2 Having unearthed relevant, high-quality, and valid information from clinical trials in relation to a clinical question generated by a patient encounter, you must answer 5 questions to successfully apply such information to your individual patient.3


1. HOW SIMILAR ARE THE STUDY PARTICIPANTS TO MY PATIENT?

Trial Participants Are Sometimes Atypical

Participants in clinical trials may differ in obvious ways such as age, sex, and clinical disease type from the patient in your office (Table 1).4 In most circumstances, these differences do not prevent you from making some useful generalizations from the literature. For example, I would be quite happy to generalize from a randomized clinical trial (RCT) of topical steroids for atopic eczema that did not use strict diagnostic criteria, provided that the description of the disease . . . [Full Text of this Article]

Groups Are Different From Individuals

Triumph of the Aggregate

Conclusions

2. DO THE OUTCOMES MAKE SENSE TO ME?

Does the Psoriasis Area Severity Index Mean Anything to You?

Sensitive Scales to Amplify Effects

Too Many Scales, and Too Many Short-term Studies

So What Should You Look For?

3. WHAT WAS THE MAGNITUDE OF TREATMENT EFFECTS?

How Big Is Big Enough?

Number Needed to Treat

4. WHAT ARE THE ADVERSE EVENTS?

Trials Are Not a Useful Source of Data on Rare But Serious Adverse Effects

Limitations of Aggregate Data

Communicating Risks

Weighing Risks and Benefits

5. WHAT ARE MY PATIENT'S VALUES?

Values and Belief Models

And If the Treatment Still Does Not Work?

CONCLUSIONS

From the Centre of Evidence-Based Dermatology, University of Nottingham, Queen's Medical Centre, Nottingham, England.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.